Full Product Name
Anti-BCOR Antibody
Product Synonym Names
KIAA1575; BCL-6 corepressor; BCoR
Product Gene Name
anti-BCOR antibody
[Similar Products]
Antibody/Peptide Pairs
BCOR peptide (MBS8217585) is used for blocking the activity of BCOR antibody (MBS8210484)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q6W2J9
Specificity
Recognizes endogenous levels of BCOR protein.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human BCOR. The exact sequence is proprietary.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Other Notes
Small volumes of anti-BCOR antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-BCOR antibody
Rabbit polyclonal antibody to BCOR
Applications Tested/Suitable for anti-BCOR antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-BCOR antibody
WB (1/500 - 1/1000), IHC (1/100 - 1/200)
Western Blot (WB) of anti-BCOR antibody
Western blot analysis of BCOR expression in HEK293T (A) whole cell lysates.

Immunohistochemistry (IHC) of anti-BCOR antibody
Immunohistochemical analysis of BCOR staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

NCBI/Uniprot data below describe general gene information for BCOR. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001116855.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001123383.1
[Other Products]
UniProt Primary Accession #
Q6W2J9
[Other Products]
UniProt Secondary Accession #
Q29RF6; Q6P4B6; Q7Z2K7; Q8TEB4; Q96DB3; Q9H232; Q9H233; Q9HCJ7; Q9NXF2; D3DWB3; D3DWB4[Other Products]
UniProt Related Accession #
Q6W2J9[Other Products]
Molecular Weight
186,235 Da
NCBI Official Full Name
BCL-6 corepressor isoform a
NCBI Official Synonym Full Names
BCL6 corepressor
NCBI Official Symbol
BCOR??[Similar Products]
NCBI Official Synonym Symbols
MAA2; ANOP2; MCOPS2
??[Similar Products]
NCBI Protein Information
BCL-6 corepressor
UniProt Protein Name
BCL-6 corepressor
Protein Family
BCL-6 corepressor
UniProt Gene Name
BCOR??[Similar Products]
UniProt Synonym Gene Names
KIAA1575; BCoR??[Similar Products]
UniProt Entry Name
BCOR_HUMAN
NCBI Summary for BCOR
The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
UniProt Comments for BCOR
BCOR: Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence specific DNA-binding proteins such as BCL6 and MLLT3. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. Involved in the repression of TFAP2A; impairs binding of BCL6 and KDM2B to TFAP2A promoter regions. Via repression of TFAP2A acts as a negative regulator of osteo-dentiogenic capacity in ***** stem cells; the function implies inhibition of methylation on histone H3 'Lys-4' (H3K4me3) and 'Lys-36' (H3K36me2). Defects in BCOR are the cause of microphthalmia syndromic type 2 (MCOPS2). Microphthalmia is a clinically heterogeneous disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. MCOPS2 is a very rare multiple congenital anomaly syndrome characterized by eye anomalies (congenital cataract, microphthalmia, or secondary glaucoma), facial abnormalities (long narrow face, high nasal bridge, pointed nose with cartilages separated at the tip, cleft palate, or submucous cleft palate), cardiac anomalies (atrial septal defect, ventricular septal defect, or floppy mitral valve) and dental abnormalities (canine radiculomegaly, delayed dentition, oligodontia, persistent primary teeth, or variable root length). Belongs to the BCOR family. 4 isoforms of the human protein are produced by alternative splicing.
Protein type: Transcription, coactivator/corepressor
Chromosomal Location of Human Ortholog: Xp11.4
Cellular Component: PcG protein complex; nucleus
Molecular Function: protein binding; histone deacetylase binding; heat shock protein binding; ubiquitin-protein ligase activity; transcription factor binding; transcription corepressor activity
Biological Process: odontogenesis; negative regulation of bone mineralization; transcription, DNA-dependent; negative regulation of histone H3-K36 methylation; heart development; specification of axis polarity; negative regulation of histone H3-K4 methylation; palate development; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent
Disease: Microphthalmia, Syndromic 2; Microphthalmia, Syndromic 1
Research Articles on BCOR
1. The nonsense and frameshift mutations, which introduce premature termination codons, were found to contribute to oculofaciocardiodental syndrome in our two patients.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.